Exendin fusion proteins

Details for Australian Patent Application No. 2007278994 (hide)

Owner BioRexis Pharmaceutical Corporation

Inventors Ballance, David James; Prior, Christopher Philip; Turner, Andrew John; Sadeghi, Homayoun

Agent Allens Arthur Robinson

Pub. Number AU-A-2007278994

PCT Pub. Number WO2008/012629

Priority 60/874,965 15.12.06 US; 60/832,582 24.07.06 US; 60/857,474 08.11.06 US

Filing date 13 July 2007

Wipo publication date 31 January 2008

International Classifications

A61K 38/22 (2006.01) Medicinal preparations containing peptides - Hormones

C07K 14/575 (2006.01) Peptides having more than 20 amino acids

C07K 19/00 (2006.01) Hybrid peptides

C12N 15/62 (2006.01) Mutation or genetic engineering - DNA sequences coding for fusion proteins

C12N 15/63 (2006.01) Mutation or genetic engineering - Introduction of foreign genetic material using vectors

Event Publications

5 February 2009 PCT application entered the National Phase

  PCT publication WO2008/012629 Priority application(s): WO2008/012629

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007279002-Packaging article

2007278986-Compositions and methods for inhibiting gastric acid secretion using derivatives of small dicarboxylic acids in combination with PPI